179 related articles for article (PubMed ID: 29083981)
21. Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers.
Yoo SK; Lee S; Kim SJ; Jee HG; Kim BA; Cho H; Song YS; Cho SW; Won JK; Shin JY; Park do J; Kim JI; Lee KE; Park YJ; Seo JS
PLoS Genet; 2016 Aug; 12(8):e1006239. PubMed ID: 27494611
[TBL] [Abstract][Full Text] [Related]
22. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
Adeniran AJ; Hui P; Chhieng DC; Prasad ML; Schofield K; Theoharis C
Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468
[TBL] [Abstract][Full Text] [Related]
23. [Molecular mechanism of thyroid carcinogenesis].
Yamashita S; Mitsutake N
Nihon Rinsho; 2007 Nov; 65(11):1959-65. PubMed ID: 18018555
[TBL] [Abstract][Full Text] [Related]
24. The Role of miRNA in Papillary Thyroid Cancer in the Context of miRNA Let-7 Family.
Perdas E; Stawski R; Nowak D; Zubrzycka M
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27314338
[TBL] [Abstract][Full Text] [Related]
25. Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.
Vanden Borre P; Schrock AB; Anderson PM; Morris JC; Heilmann AM; Holmes O; Wang K; Johnson A; Waguespack SG; Ou SI; Khan S; Fung KM; Stephens PJ; Erlich RL; Miller VA; Ross JS; Ali SM
Oncologist; 2017 Mar; 22(3):255-263. PubMed ID: 28209747
[TBL] [Abstract][Full Text] [Related]
26. Role and relevance of BRAF mutations in risk stratifying patients of papillary thyroid cancers along with a review of literature.
Krishnamurthy A; Ramshankar V; Murherkar K; Vidyarani S; Raghunandhan GC; Das A; Desai PB; Albert K
Indian J Cancer; 2017; 54(1):372-378. PubMed ID: 29199726
[TBL] [Abstract][Full Text] [Related]
27. [Molecular Aspects of Thyroid Tumors with Emphasis on MicroRNA and Their Clinical Implications].
Ludvíková M; Kholová I; Kalfeřt D
Klin Onkol; 2017; 30(3):167-174. PubMed ID: 28612612
[TBL] [Abstract][Full Text] [Related]
28. BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications.
Tang KT; Lee CH
J Chin Med Assoc; 2010 Mar; 73(3):113-28. PubMed ID: 20230995
[TBL] [Abstract][Full Text] [Related]
29. [BRAF gene mutation in the natural history of papillary thyroid carcinoma: diagnostic and prognostic implications].
Lopes JP; Fonseca E
Acta Med Port; 2011 Dec; 24 Suppl 4():855-68. PubMed ID: 22863493
[TBL] [Abstract][Full Text] [Related]
30. The epigenetic landscape of differentiated thyroid cancer.
Asa SL; Ezzat S
Mol Cell Endocrinol; 2018 Jul; 469():3-10. PubMed ID: 28711609
[TBL] [Abstract][Full Text] [Related]
31. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
32. Anaplastic Transformation in Mandibular Metastases of Follicular Variant of Papillary Thyroid Carcinoma: A Case Report and Review of the Literature.
Ambelil M; Sultana S; Roy S; Gonzalez MM
Ann Clin Lab Sci; 2016 Sep; 46(5):552-6. PubMed ID: 27650625
[TBL] [Abstract][Full Text] [Related]
33. Gene-expression profiling in differentiated thyroid cancer--a viable strategy for the practice of genomic medicine?
Weber F; Eng C
Future Oncol; 2005 Aug; 1(4):497-510. PubMed ID: 16556026
[TBL] [Abstract][Full Text] [Related]
34. Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer.
Sohn SY; Park WY; Shin HT; Bae JS; Ki CS; Oh YL; Kim SW; Chung JH
Thyroid; 2016 May; 26(5):672-82. PubMed ID: 26971368
[TBL] [Abstract][Full Text] [Related]
35. [Fetal cell carcinogenesis hypothesis and the prospect of future laboratory tests].
Takano T
Rinsho Byori; 2009 Aug; 57(8):761-8. PubMed ID: 19764411
[TBL] [Abstract][Full Text] [Related]
36. Gene Fusions in Thyroid Cancer.
Yakushina VD; Lerner LV; Lavrov AV
Thyroid; 2018 Feb; 28(2):158-167. PubMed ID: 29281951
[TBL] [Abstract][Full Text] [Related]
37. The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes.
Pagan M; Kloos RT; Lin CF; Travers KJ; Matsuzaki H; Tom EY; Kim SY; Wong MG; Stewart AC; Huang J; Walsh PS; Monroe RJ; Kennedy GC
BMC Bioinformatics; 2016 Jan; 17 Suppl 1(Suppl 1):6. PubMed ID: 26818556
[TBL] [Abstract][Full Text] [Related]
38. Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.
Penna GC; Vaisman F; Vaisman M; Sobrinho-Simões M; Soares P
Cytogenet Genome Res; 2016; 150(3-4):194-207. PubMed ID: 28231576
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profile of human thyroid cancer in relation to its mutational status.
Rusinek D; Szpak-Ulczok S; Jarzab B
J Mol Endocrinol; 2011 Dec; 47(3):R91-103. PubMed ID: 21798995
[TBL] [Abstract][Full Text] [Related]
40. Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma.
Rubinstein JC; Brown TC; Christison-Lagay ER; Zhang Y; Kunstman JW; Juhlin CC; Nelson-Williams C; Goh G; Quinn CE; Callender GG; Udelsman R; Lifton RP; Korah R; Carling T
BMC Cancer; 2016 Aug; 16():646. PubMed ID: 27538953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
